Metformin News and Research

RSS
Metformin is the active ingredient in a drug used to treat diabetes mellitus (a condition in which the body cannot control the level of sugar in the blood). It is also being studied in the treatment of cancer. It decreases the amount of glucose (a type of sugar) released into the bloodstream from the liver and increases the body’s use of the glucose. Metformin is a type of antidiabetic agent.
Youth-onset type 2 diabetes is more aggressive and difficult to control, study shows

Youth-onset type 2 diabetes is more aggressive and difficult to control, study shows

Study evaluates the difference in weight loss caused by two antidiabetic medications

Study evaluates the difference in weight loss caused by two antidiabetic medications

Statin use among heart failure patients can reduce cancer risk

Statin use among heart failure patients can reduce cancer risk

Statins associated with reduced COVID-19 mortality and decreased need for ventilator support

Statins associated with reduced COVID-19 mortality and decreased need for ventilator support

Metformin prevents pulmonary or lung inflammation in animals infected with SARS-CoV-2

Metformin prevents pulmonary or lung inflammation in animals infected with SARS-CoV-2

Metformin potently inhibits SARS-CoV-2-induced cytokine release in monocytes

Metformin potently inhibits SARS-CoV-2-induced cytokine release in monocytes

Asthma patients can benefit from type 2 diabetes medication

Asthma patients can benefit from type 2 diabetes medication

GeroSense AI tracks biological age and resilience via smartphone sensor data

GeroSense AI tracks biological age and resilience via smartphone sensor data

Study examines risk phenotypes of diabetes and their association with COVID-19 severity

Study examines risk phenotypes of diabetes and their association with COVID-19 severity

Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model

Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

Anti-diabetic drug phenformin may prompt stronger cancer-fighting activities

Parkinson's disease, type 2 diabetes, and cancer share the same pathway, shows study

Parkinson's disease, type 2 diabetes, and cancer share the same pathway, shows study

Hopkins Medicine endocrinologist publishes first clinical practice review on diabetes management

Hopkins Medicine endocrinologist publishes first clinical practice review on diabetes management

Diabetes drug appears to exploit vulnerability of AIDS-causing retrovirus HIV

Diabetes drug appears to exploit vulnerability of AIDS-causing retrovirus HIV

Type 2 diabetes drug can successfully reduce symptoms associated with tuberous sclerosis complex

Type 2 diabetes drug can successfully reduce symptoms associated with tuberous sclerosis complex

Researchers explore a case of diabetic ketoacidosis in patient with atezolizumab-induced autoimmune diabetes

Researchers explore a case of diabetic ketoacidosis in patient with atezolizumab-induced autoimmune diabetes

Scientists seek Covid treatment answers in cheap, older drugs

Scientists seek Covid treatment answers in cheap, older drugs

Antidiabetic drug could help reduce chronic inflammation in people living with HIV

Antidiabetic drug could help reduce chronic inflammation in people living with HIV

Study: Semaglutide drug promotes weight loss in patients with type 2 diabetes

Study: Semaglutide drug promotes weight loss in patients with type 2 diabetes

Study: Body produces large amounts of GDF15 hormone during extended bouts of vigorous exercise

Study: Body produces large amounts of GDF15 hormone during extended bouts of vigorous exercise